FDA Announces Approval of Study on Direct-to-Consumer Prescription Drug Advertisements

Summary

The U.S. Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on an experimental study examining the impact of promotional offers in direct-to-consumer prescription drug print advertisements on consumer perceptions of products.